Accretive Health
AH
AH was delisted on the 14th of March, 2014.
99 hedge funds and large institutions have $469M invested in Accretive Health in 2013 Q3 according to their latest regulatory filings, with 17 funds opening new positions, 41 increasing their positions, 24 reducing their positions, and 15 closing their positions.
71% more repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 24
55% more call options, than puts
Call options by funds: $3.29M | Put options by funds: $2.12M
13% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 15
1% more funds holding
Funds holding: 98 → 99 (+1)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
18% less capital invested
Capital invested by funds: $572M → $469M (-$103M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PCM
Proxima Capital Management
New York
|
+$8.83M |
| 2 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
+$8.45M |
| 3 |
Neuberger Berman Group
New York
|
+$5.87M |
| 4 |
D.E. Shaw & Co
New York
|
+$4.92M |
| 5 |
ClearBridge Investments
New York
|
+$4.75M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
TimesSquare Capital Management
New York
|
-$18.2M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$8.45M |
| 3 |
NRC
North Run Capital
Boston,
Massachusetts
|
-$8.07M |
| 4 |
KCM
Kennedy Capital Management
St Louis,
Missouri
|
-$7.02M |
| 5 |
SC
Sageview Capital
Greenwich,
Connecticut
|
-$5.65M |
AH Hedge Fund Activity: Q3 2013 in Review
99 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Accretive Health (AH) for Q3 2013, worth a combined $469M — down 18% from $572M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new AH positions and 15 closed out — a net gain of 2 holders — while 41 added to existing stakes and 24 trimmed.
The largest buyer was Proxima Capital Management, opening a new position worth an estimated $8.83M. The largest seller was TimesSquare Capital Management, exiting entirely with an estimated $18.2M sold.
- 99 institutional investors held Accretive Health (AH) as of Q3 2013, up from 98 in Q2 2013.
- Funds reported $469M of Accretive Health stock for Q3 2013, down 18% quarter-over-quarter.
- 17 funds opened new Accretive Health positions in Q3 2013 and 15 closed out, a net change of +2 holders.
- The largest Accretive Health buyer in Q3 2013 was Proxima Capital Management, an estimated $8.83M added.
- The largest Accretive Health seller in Q3 2013 was TimesSquare Capital Management, an estimated $18.2M sold.
Based on aggregated 13F filings for Q3 2013.